Regeneron BLA for Rilonacept Extended Three Months By FDA
Company has submitted additional data on chemistry, manufacturing and controls for the IL-1 Trap for rare inflammatory conditions.
Company has submitted additional data on chemistry, manufacturing and controls for the IL-1 Trap for rare inflammatory conditions.